Markets wobble as ceasefire talk masks a still-blocked oil lifeline and investors struggle to price what comes next.

Investors today birched Cochlear shares by close to 40% after a radical earnings update – their worst fall in 30 years.

A string of ASX-listed drug developers is due to release company-making – or breaking – pivotal clinical study results in ...

Meteoric Resources charged higher on a $40m cap raise to advance its Caldeira project and strong sentiment in Brazil’s rare earth sector.

Companies replacing thousands of workers with AI agents have created a massive invisible cyber attack surface.

Healthcare stocks copped a hiding after Cochlear’s brutal sell-off spilled across the sector, with banks also under pressure.

Riversgold (ASX:RGL) is progressing its Northern Zone project near Kalgoorlie in WA toward development with a preliminary ...

Australian miners - and scientists - are at the forefront of a new world order for a reliable supply of rare earths.

Management buying shares in a company is often seen as a positive as it implies the buyer has enough confidence to have “skin ...

Helium shortages are squeezing chipmakers and instead of chasing supply, Adisyn is betting on redesigning chips to need less ...

As China flexes its dominance over critical minerals, Japan and Australia are moving to secure independent rare earths supply ...

Can the team behind Latin Resources's success repeat the feat at Solis Minerals? Plus, a US$2.8bn deal puts focus on ...